logo-large
  • Browse Categories

Publications by authors named "Yeng Shaw"

Claim this Profile
D
Dyr726, a brain-penetrant inhibitor of PI3Kα, Type III receptor tyrosine kinases, and WNT signaling.
Vasudha Tandon, Alessandra Fistrovich, Joaquina Nogales, Febe Ferro, Samantha N Rokey, Yeng Shaw

bioRxiv· March 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1B.
Gerrit Wilms, Kevin Schofield, Shayna Maddern, Christopher Foley, Yeng Shaw

J Med Chem· October 2024


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity.
Bangfu Zhu, Tom Parsons, Christopher Foley, Yeng Shaw, Travis Dunckley

Sci Rep· September 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: